Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 357

1.

Correction to: Outcomes of hypercalcemia of malignancy in patients with solid cancer: a national inpatient analysis.

Bhandari S, Kumar R, Tripathi P, Chan A, Mudra S, Redman R.

Med Oncol. 2019 Nov 1;36(12):100. doi: 10.1007/s12032-019-1319-4.

PMID:
31673861
2.

Outcomes of hypercalcemia of malignancy in patients with solid cancer: a national inpatient analysis.

Bhandari S, Kumar R, Tripathi P, Chan A, Mudra S, Redman R.

Med Oncol. 2019 Sep 16;36(10):90. doi: 10.1007/s12032-019-1315-8. Erratum in: Med Oncol. 2019 Nov 1;36(12):100.

PMID:
31529163
3.

Salivary and serum biomarkers of inflammation in a man with metastatic medullary thyroid carcinoma and hyperreactive gingiva: a fourteen year odyssey.

Redman RS, Bayley NC, Nylén ES.

Biotech Histochem. 2019 Aug;94(6):389-397. doi: 10.1080/10520295.2019.1649463. Epub 2019 Aug 19.

PMID:
31423894
4.

Trastuzumab deruxtecan (DS-8201a) in patients with advanced HER2-positive breast cancer previously treated with trastuzumab emtansine: a dose-expansion, phase 1 study.

Tamura K, Tsurutani J, Takahashi S, Iwata H, Krop IE, Redfern C, Sagara Y, Doi T, Park H, Murthy RK, Redman RA, Jikoh T, Lee C, Sugihara M, Shahidi J, Yver A, Modi S.

Lancet Oncol. 2019 Jun;20(6):816-826. doi: 10.1016/S1470-2045(19)30097-X. Epub 2019 Apr 29. Erratum in: Lancet Oncol. 2019 May 10;:.

PMID:
31047803
5.

Ombitasvir/paritaprevir/ritonavir plus ribavirin for 24 weeks in patients with HCV GT4 and compensated cirrhosis (AGATE-I Part II).

Asselah T, Alami NN, Moreno C, Pol S, Karatapanis S, Gschwantler M, Horsmans Y, Elefsiniotis I, Larrey D, Ferrari C, Rizzetto M, Orlandini A, Calleja JL, Bruno S, Schnell G, Qaqish R, Redman R, Pilot-Matias T, Kopecky-Bromberg S, Yu Y, Mobashery N.

Health Sci Rep. 2019 Mar 1;2(3):e92. doi: 10.1002/hsr2.92. eCollection 2019 Mar.

6.

Dual-Energy Computed Tomography Pulmonary Angiography: Comparison of Vessel Enhancement between Linear Blended and Virtual Monoenergetic Reconstruction Techniques.

Murphy A, Cheng J, Pratap J, Redman R, Coucher J.

J Med Imaging Radiat Sci. 2019 Mar;50(1):62-67. doi: 10.1016/j.jmir.2018.10.009. Epub 2018 Dec 4.

PMID:
30777250
7.

Prognostic factors and selection criteria in the retreatment of head and neck cancers.

May ME Jr, Cash ED, Silverman CL, Redman RA, Perez CA, Wilson LD, Tennant PA, Bumpous JM, Dunlap NE.

Oral Oncol. 2019 Jan;88:85-90. doi: 10.1016/j.oraloncology.2018.11.024. Epub 2018 Nov 22.

PMID:
30616802
8.

Quality Appraisal of Systematic Reviews for Behavioral Treatments of Attention Disorders in Traumatic Brain Injury.

Roitsch J, Redman R, Michalek AMP, Johnson RK, Raymer AM.

J Head Trauma Rehabil. 2019 Jul/Aug;34(4):E42-E50. doi: 10.1097/HTR.0000000000000444.

PMID:
30499927
9.

Positive Association Between Neutrophil-Lymphocyte Ratio and Presence of Panoramically Imaged Carotid Atheromas Among Men.

Friedlander AH, Lee UK, Polanco JC, Tran HA, Chang TI, Redman RS.

J Oral Maxillofac Surg. 2019 Feb;77(2):321-327. doi: 10.1016/j.joms.2018.09.038. Epub 2018 Oct 11.

PMID:
30395820
10.

Critical appraisal of systematic reviews of executive function treatments in TBI.

Raymer AM, Roitsch J, Redman R, Michalek AMP, Johnson RK.

Brain Inj. 2018;32(13-14):1601-1611. doi: 10.1080/02699052.2018.1522671. Epub 2018 Sep 21.

PMID:
30240277
11.

Predictors of Turnover Among Asian Foreign-Educated Nurses in Their 1st Year of US Employment.

Geun HG, Redman RW, McCullagh MC.

J Nurs Adm. 2018 Oct;48(10):519-525. doi: 10.1097/NNA.0000000000000660.

PMID:
30239448
12.

Biodiversity and Abundance of Cultured Microfungi from the Permanently Ice-Covered Lake Fryxell, Antarctica.

Connell L, Segee B, Redman R, Rodriguez RJ, Staudigel H.

Life (Basel). 2018 Sep 6;8(3). pii: E37. doi: 10.3390/life8030037.

13.

Viral DNA integration and methylation of human papillomavirus type 16 in high-grade oral epithelial dysplasia and head and neck squamous cell carcinoma.

Khanal S, Shumway BS, Zahin M, Redman RA, Strickley JD, Trainor PJ, Rai SN, Ghim SJ, Jenson AB, Joh J.

Oncotarget. 2018 Jul 13;9(54):30419-30433. doi: 10.18632/oncotarget.25754. eCollection 2018 Jul 13.

14.

Characterization of demographics and NS5A genetic diversity for hepatitis C virus genotype 4-infected patients with or without cirrhosis treated with ombitasvir/paritaprevir/ritonavir.

Schnell G, Tripathi R, Beyer J, Reisch T, Krishnan P, Dekhtyar T, Irvin M, Hall C, Yu Y, Mobashery N, Redman R, Pilot-Matias T, Collins C.

J Viral Hepat. 2018 Sep;25(9):1078-1088. doi: 10.1111/jvh.12906. Epub 2018 May 8.

PMID:
29624809
15.

Integrated Resistance Analysis of CERTAIN-1 and CERTAIN-2 Studies in Hepatitis C Virus-Infected Patients Receiving Glecaprevir and Pibrentasvir in Japan.

Krishnan P, Schnell G, Tripathi R, Beyer J, Reisch T, Dekhtyar T, Irvin M, Xie W, Fu B, Burroughs M, Redman R, Kumada H, Chayama K, Collins C, Pilot-Matias T.

Antimicrob Agents Chemother. 2018 Jan 25;62(2). pii: e02217-17. doi: 10.1128/AAC.02217-17. Print 2018 Feb.

16.

Correction to: Efficacy and safety of glecaprevir/pibrentasvir in HCV-infected Japanese patients with prior DAA experience, severe renal impairment, or genotype 3 infection.

Kumada H, Watanabe T, Suzuki F, Ikeda K, Sato K, Toyoda H, Atsukawa M, Ido A, Takaki A, Enomoto N, Kato K, Alves K, Burroughs M, Redman R, Pugatch D, Pilot-Matias TJ, Krishnan P, Oberoi RK, Xie W, Chayama K.

J Gastroenterol. 2018 May;53(5):689. doi: 10.1007/s00535-017-1409-z.

17.

Efficacy and safety of glecaprevir/pibrentasvir in HCV-infected Japanese patients with prior DAA experience, severe renal impairment, or genotype 3 infection.

Kumada H, Watanabe T, Suzuki F, Ikeda K, Sato K, Toyoda H, Atsukawa M, Ido A, Takaki A, Enomoto N, Kato K, Alves K, Burroughs M, Redman R, Pugatch D, Pilot-Matias TJ, Krishnan P, Oberoi RK, Xie W, Chayama K.

J Gastroenterol. 2018 Apr;53(4):566-575. doi: 10.1007/s00535-017-1396-0. Epub 2017 Oct 20. Erratum in: J Gastroenterol. 2017 Nov 13;:.

18.

Efficacy and safety of glecaprevir/pibrentasvir in Japanese patients with chronic genotype 1 hepatitis C virus infection with and without cirrhosis.

Chayama K, Suzuki F, Karino Y, Kawakami Y, Sato K, Atarashi T, Naganuma A, Watanabe T, Eguchi Y, Yoshiji H, Seike M, Takei Y, Kato K, Alves K, Burroughs M, Redman R, Pugatch DL, Pilot-Matias TJ, Krishnan P, Oberoi RK, Xie W, Kumada H.

J Gastroenterol. 2018 Apr;53(4):557-565. doi: 10.1007/s00535-017-1391-5. Epub 2017 Sep 25.

19.

Botryoid odontogenic cyst. Exploration of proliferative activity, apoptosis and expression of TP53 and BCL2 compared to the histologically identical lateral periodontal and gingival cysts.

Redman RS, Paal E, Chauhan S, Avers R, Bayley N.

Biotech Histochem. 2017;92(8):569-576. doi: 10.1080/10520295.2017.1367231. Epub 2017 Sep 14.

PMID:
28910164
20.

Efficacy and safety of glecaprevir/pibrentasvir in Japanese patients with chronic genotype 2 hepatitis C virus infection.

Toyoda H, Chayama K, Suzuki F, Sato K, Atarashi T, Watanabe T, Atsukawa M, Naganuma A, Notsumata K, Osaki Y, Nakamuta M, Takaguchi K, Saito S, Kato K, Pugatch D, Burroughs M, Redman R, Alves K, Pilot-Matias TJ, Oberoi RK, Fu B, Kumada H.

Hepatology. 2018 Feb;67(2):505-513. doi: 10.1002/hep.29510. Epub 2017 Nov 24.

21.

Resistance characterization of hepatitis C virus genotype 2 from Japanese patients treated with ombitasvir and paritaprevir/ritonavir.

Schnell G, Tripathi R, Krishnan P, Beyer J, Reisch T, Irvin M, Dekhtyar T, Setze C, Rodrigues L Jr, Alves K, Burroughs M, Redman R, Chayama K, Kumada H, Collins C, Pilot-Matias T.

J Med Virol. 2018 Jan;90(1):109-119. doi: 10.1002/jmv.24923. Epub 2017 Sep 22.

22.

Neck dissection for unknown cancer of the head and neck in the era of chemoradiation.

Amsbaugh MJ, Yusuf M, Gaskins J, Silverman C, Potts K, Bumpous J, Redman R, Perez C, Dunlap N.

Am J Otolaryngol. 2017 Sep - Oct;38(5):588-592. doi: 10.1016/j.amjoto.2017.06.006. Epub 2017 Jun 14.

PMID:
28633765
23.

Microcalcifications in stone-obstructed human submandibular gland are associated with apoptosis and cell proliferation.

Lau I, Potluri A, Ibeh CL, Redman RS, Paal E, Bandyopadhyay BC.

Arch Oral Biol. 2017 Oct;82:99-108. doi: 10.1016/j.archoralbio.2017.05.001. Epub 2017 Jun 7.

24.

Randomized Phase 3 Trial of Ombitasvir/Paritaprevir/Ritonavir and Ribavirin for Hepatitis C Virus Genotype 2-Infected Japanese Patients.

Sato K, Chayama K, Alves K, Toyoda H, Suzuki F, Kato K, Rodrigues L Jr, Zhang X, Setze C, Pilot-Matias T, Burroughs M, Redman R, Kumada H.

Adv Ther. 2017 Jun;34(6):1449-1465. doi: 10.1007/s12325-017-0506-y. Epub 2017 May 23.

PMID:
28536999
25.

A successful model for longitudinal community-engaged health research: the 2040 Partners for Health Student Program.

Redman RM, Reinsvold MC, Reddy A, Bennett PE, Hoerauf JM, Puls KM, Ovrutsky AR, Ly AR, White G, McNeil O, Meredith JJ.

Fam Pract. 2017 Jun 1;34(3):341-346. doi: 10.1093/fampra/cmx025.

26.

Ombitasvir, paritaprevir, and ritonavir plus ribavirin for chronic hepatitis C virus genotype 4 infection in Egyptian patients with or without compensated cirrhosis (AGATE-II): a multicentre, phase 3, partly randomised open-label trial.

Waked I, Shiha G, Qaqish RB, Esmat G, Yosry A, Hassany M, Soliman R, Mohey MA, Allam N, Zayed N, Asselah T, Hall C, Redman R, Mobashery N, Doss W.

Lancet Gastroenterol Hepatol. 2016 Sep;1(1):36-44. doi: 10.1016/S2468-1253(16)30002-4. Epub 2016 Jun 16. Erratum in: Lancet Gastroenterol Hepatol. 2016 Sep;1(1):e1.

PMID:
28404110
27.

Ombitasvir, paritaprevir, and ritonavir plus ribavirin in adults with hepatitis C virus genotype 4 infection and cirrhosis (AGATE-I): a multicentre, phase 3, randomised open-label trial.

Asselah T, Hézode C, Qaqish RB, ElKhashab M, Hassanein T, Papatheodoridis G, Feld JJ, Moreno C, Zeuzem S, Ferenci P, Yu Y, Redman R, Pilot-Matias T, Mobashery N.

Lancet Gastroenterol Hepatol. 2016 Sep;1(1):25-35. doi: 10.1016/S2468-1253(16)30001-2. Epub 2016 Jun 16.

PMID:
28404108
28.

High-dose versus weekly cisplatin definitive chemoradiotherapy for HPV-related oropharyngeal squamous cell carcinoma of the head and neck.

Perez CA, Wu X, Amsbaugh MJ, Gosain R, Claudino WM, Yusuf M, Roberts T, Jain D, Jenson A, Khanal S, Silverman CI, Tennant P, Bumpous JM, Dunlap NE, Rai SN, Redman RA.

Oral Oncol. 2017 Apr;67:24-28. doi: 10.1016/j.oraloncology.2017.01.010. Epub 2017 Feb 3.

PMID:
28351577
29.

Gender differences in use of hearing protection devices among farm operators.

McCullagh MC, Banerjee T, Yang JJ, Bernick J, Duffy S, Redman R.

Noise Health. 2016 Nov-Dec;18(85):368-375. doi: 10.4103/1463-1741.195803.

30.

Improving Nursing Communication Skills in an Intensive Care Unit Using Simulation and Nursing Crew Resource Management Strategies: An Implementation Project.

Turkelson C, Aebersold M, Redman R, Tschannen D.

J Nurs Care Qual. 2017 Oct/Dec;32(4):331-339. doi: 10.1097/NCQ.0000000000000241.

PMID:
27875384
31.

Communication Between Acute Care Hospitals and Skilled Nursing Facilities During Care Transitions: A Retrospective Chart Review.

Jusela C, Struble L, Gallagher NA, Redman RW, Ziemba RA.

J Gerontol Nurs. 2017 Mar 1;43(3):19-28. doi: 10.3928/00989134-20161109-03. Epub 2016 Nov 15.

PMID:
27845810
32.

Distribution of Cervical Lymph Node Metastases From Squamous Cell Carcinoma of the Oropharynx in the Era of Risk Stratification Using Human Papillomavirus and Smoking Status.

Amsbaugh MJ, Yusuf M, Cash E, Silverman C, Wilson E, Bumpous J, Potts K, Perez C, Bert R, Redman R, Dunlap N.

Int J Radiat Oncol Biol Phys. 2016 Oct 1;96(2):349-353. doi: 10.1016/j.ijrobp.2016.06.2450. Epub 2016 Jun 25.

PMID:
27598805
33.

Organ preservation with neoadjuvant chemoradiation in patients with orbit invasive sinonasal cancer otherwise requiring exenteration.

Amsbaugh MJ, Yusuf M, Silverman C, Bumpous J, Perez CA, Potts K, Tennant P, Redman R, Dunlap N.

Radiat Oncol J. 2016 Sep;34(3):209-215. Epub 2016 Sep 5.

34.

Specialized Microbiome of a Halophyte and its Role in Helping Non-Host Plants to Withstand Salinity.

Yuan Z, Druzhinina IS, Labbé J, Redman R, Qin Y, Rodriguez R, Zhang C, Tuskan GA, Lin F.

Sci Rep. 2016 Aug 30;6:32467. doi: 10.1038/srep32467.

35.

Detection of a new microsporidium Perezia sp. in shrimps Penaeus monodon and P. indicus by histopathology, in situ hybridization and PCR.

Han JE, Tang KF, Pantoja CR, Lightner DV, Redman RM, Le Groumellec M.

Dis Aquat Organ. 2016 Jul 7;120(2):165-71. doi: 10.3354/dao03022.

PMID:
27409240
36.

Prognostic significance of HPV status in postoperative squamous-cell carcinoma of the head and neck.

Bertke MH, Shaughnessy JN, Forsthoefel MK, Cash LD, Silverman CL, Bumpous JM, Potts KL, Redman RA, Perez CA, Dunlap NE.

J Community Support Oncol. 2016 May;14(5):215-20. doi: 10.12788/jcso.0252.

PMID:
27258054
37.

Turnover and Associated Factors in Asian Foreign-Educated Nurses.

Geun HG, Redman RW, McCullagh MC.

J Nurs Adm. 2016 May;46(5):271-7. doi: 10.1097/NNA.0000000000000342.

PMID:
27093183
38.

Exposure-Response Relationship for Ombitasvir and Paritaprevir/Ritonavir in Hepatitis C Virus Subgenotype 1b-Infected Japanese Patients in the Phase 3 Randomized GIFT-I Study.

Gopalakrishnan S, Khatri A, Mensing S, Redman R, Menon R, Zha J.

Adv Ther. 2016 Apr;33(4):670-83. doi: 10.1007/s12325-016-0320-y. Epub 2016 Mar 21.

PMID:
27084721
39.

Cyclical hypofractionated radiotherapy technique for palliative treatment of locally advanced head and neck cancer: institutional experience and review of palliative regimens.

Finnegan TS, Bhatt NH, Shaughnessy JN, Perez C, Redman R, Silverman C, Bumpous J, Potts K, Dunlap NE.

J Community Support Oncol. 2016 Jan;14(1):29-36. doi: 10.12788/jcso.0201.

PMID:
26870840
40.

Salivary and serum procalcitonin and C-reactive protein as biomarkers of periodontitis in United States veterans with osteoarthritis or rheumatoid arthritis.

Redman RS, Kerr GS, Payne JB, Mikuls TR, Huang J, Sayles HR, Becker KL, Nylén ES.

Biotech Histochem. 2016;91(2):77-85. doi: 10.3109/10520295.2015.1082625.

41.

Pharmacological and clinical profile of lenvatinib (E-7080) in the treatment of advanced, radioiodine-refractory, differentiated thyroid cancer.

Hegazi M, Azadi A, Jain D, Redman R, Perez CA.

Drugs Today (Barc). 2015 Dec;51(12):689-94. doi: 10.1358/dot.2015.51.12.2420390. Review.

PMID:
26798849
42.
43.

Analysis of Hepatitis C Virus Genotype 1b Resistance Variants in Japanese Patients Treated with Paritaprevir-Ritonavir and Ombitasvir.

Krishnan P, Schnell G, Tripathi R, Beyer J, Reisch T, Zhang X, Setze C, Rodrigues L Jr, Burroughs M, Redman R, Chayama K, Kumada H, Collins C, Pilot-Matias T.

Antimicrob Agents Chemother. 2015 Dec 7;60(2):1106-13. doi: 10.1128/AAC.02606-15. Print 2016 Feb.

44.

Perception of Jordanian nurses regarding involvement in decision-making.

Al-Hamdan ZM, Bawadi HA, Redman RW, Al-Nawafleh AH.

Appl Nurs Res. 2016 May;30:e1-5. doi: 10.1016/j.apnr.2015.06.013. Epub 2015 Jun 28.

PMID:
26602959
45.

Drug Interactions Between Hepatoprotective Agents Ursodeoxycholic Acid or Glycyrrhizin and Ombitasvir/Paritaprevir/Ritonavir in Healthy Japanese Subjects.

Zha J, Badri PS, Ding B, Uchiyama N, Alves K, Rodrigues L Jr, Redman R, Dutta S, Menon RM.

Clin Ther. 2015 Nov 1;37(11):2560-71. doi: 10.1016/j.clinthera.2015.09.015. Epub 2015 Oct 23.

PMID:
26505529
46.

Genome sequence of the plant growth promoting endophytic yeast Rhodotorula graminis WP1.

Firrincieli A, Otillar R, Salamov A, Schmutz J, Khan Z, Redman RS, Fleck ND, Lindquist E, Grigoriev IV, Doty SL.

Front Microbiol. 2015 Sep 17;6:978. doi: 10.3389/fmicb.2015.00978. eCollection 2015. No abstract available.

47.

A critical examination of developments in nursing doctoral education in the United States.

Ketefian S, Redman RW.

Rev Lat Am Enfermagem. 2015 May-Jun;23(3):363-71. doi: 10.1590/0104-1169.0797.2566. English, Portuguese, Spanish.

48.

Safety and Tolerability of Doripenem in Hospitalized Children With Complicated Intra-Abdominal Infection, Complicated Urinary Tract Infections and Pneumonia.

Cannavino CR, Castaneda-Ruiz B, Redman R, Go O, Cirillo I, Barauskas V, Senatorova G, Emeryk A, Bradley JS.

Pediatr Infect Dis J. 2015 Nov;34(11):1264-7. doi: 10.1097/INF.0000000000000859.

PMID:
26226440
49.

Efficacy and Safety of Ombitasvir, Paritaprevir, and Ritonavir in an Open-Label Study of Patients With Genotype 1b Chronic Hepatitis C Virus Infection With and Without Cirrhosis.

Lawitz E, Makara M, Akarca US, Thuluvath PJ, Preotescu LL, Varunok P, Morillas RM, Hall C, Mobashery N, Redman R, Pilot-Matias T, Vilchez RA, Hézode C.

Gastroenterology. 2015 Oct;149(4):971-80.e1. doi: 10.1053/j.gastro.2015.07.001. Epub 2015 Jul 11.

50.

Randomized phase 3 trial of ombitasvir/paritaprevir/ritonavir for hepatitis C virus genotype 1b-infected Japanese patients with or without cirrhosis.

Kumada H, Chayama K, Rodrigues L Jr, Suzuki F, Ikeda K, Toyoda H, Sato K, Karino Y, Matsuzaki Y, Kioka K, Setze C, Pilot-Matias T, Patwardhan M, Vilchez RA, Burroughs M, Redman R.

Hepatology. 2015 Oct;62(4):1037-46. doi: 10.1002/hep.27972. Epub 2015 Aug 25.

Supplemental Content

Loading ...
Support Center